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Abstract: Bacteria possess multiple mechanisms to survive exposure to various chemical

stresses and antimicrobial compounds. In the enteric bacterium Escherichia coli, three
homologous transcription factors—MarA, SoxS, and Rob—play a central role in
coordinating this response. Three separate systems are known to regulate the expression
and activities of MarA, SoxS, and Rob. However, a number of studies have shown that the
three do not function in isolation but rather are coregulated through transcriptional cross
talk. In this work, we systematically investigated the extent of transcriptional cross talk in
the mar-sox-rob regulon. While the three transcription factors were found to have the
potential to regulate each other's expression when ectopically expressed, the only
significant interactions observed under physiological conditions were between mar and rob
systems. MarA, SoxS, and Rob all activate the marRAB promoter, more so when they are
induced by their respective inducers: salicylate, paraquat, and decanoate. None of the
three proteins affects the soxS promoter, though unexpectedly, it was mildly repressed by
decanoate by an unknown mechanism. SoxS is the only one of the three proteins to
repress the rob promoter. Surprisingly, salicylate somewhat activates transcription of rob,
while decanoate represses it a bit. Rob, in turn, activates not only its downstream
promoters in response to salicylate but also the marRAB promoter. These results
demonstrate that the mar and rob systems function together in response to salicylate.
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The enteric bacterium Escherichia coli can resist a broad spectrum of antimicrobial compounds by
altering its metabolism and physiology (2, 26, 27, 56). These changes include expressing multidrug efflux
pumps and superoxide dismutases, redirecting metabolic flux, and altering outer membrane porin
composition (3, 5, 11, 26, 28, 48). Three homologous AraC/XylS-type transcription factors—MarA, SoxS,
and Rob—play a central role in governing this coordinated response (35, 41). The three regulate a
common set of genes known as the mar-sox-rob regulon. They do so by binding to the same degenerate
operator site within the promoters of these genes (24, 25, 29, 30). Despite the overlapping nature of this
regulon, MarA, SoxS, and Rob can differentially activate these promoters (31), enabling the cell to tune
its response to specific chemical stresses and antimicrobial compounds.
Three separate systems are known to individually regulate the respective expression and activities of
MarA, SoxS, and Rob in response to these different chemical signals. MarA is regulated at the
transcriptional level by the MarR repressor (12). The genes for these two proteins are encoded within the
marRAB operon. MarR regulates the transcription of this operon in response to phenolic compounds
such as salicylate and 2,3-dihydroxybenzoate (1, 10, 13, 33, 36, 55). In addition, MarA can bind to and
activate the marRAB promoter (32). An interesting feature of the marRAB operon is that its transcription
is governed by both a negative feedback loop involving MarR and a positive one involving MarA.
SoxS is also transcriptionally regulated, albeit in a different manner than MarA. SoxR, a [2Fe-2S]
cluster containing a transcriptional regulator found in many bacterial species (19, 21, 47), positively
regulates the expression of SoxS in response to redox-cycling compounds such as paraquat and
plumbagin (19, 20, 45, 60). Oxidation of the [2Fe-2S] cluster by these redox-cycling compounds activates
SoxR (16), which in turn activates soxS transcription (22, 23, 60). In addition, SoxR and SoxS both
repress their own transcription (23, 46).
Unlike MarA and SoxS, Rob is regulated posttranslationally by a sequestration-dispersal mechanism
(15). When Rob is inactive, it forms clusters within the cell. These clusters are thought to sequester Rob
and prevent it from activating its target promoters. A number of diverse compounds, including 2,2’dipyridyl, deoxycholate, and decanoate, activate Rob (49, 50). When these compounds activate Rob, it
no longer aggregates within these clusters and thus is free to activate the transcription of its target
genes.
Although MarA, SoxS, and Rob are regulated by distinct systems, they can also regulate each other’s
expression. Both MarA and SoxS are known to repress the rob promoter (37, 38, 54), and SoxS, Rob,
and MarA are known to activate the marRAB promoter (32, 34, 40, 58). These results suggest that the
mar-sox-rob regulon may be highly interconnected through transcriptional cross talk. In this work, we
aimed to systematically study both self-regulation and cross-regulation, particularly using canonical
inducers and deletions of chromosomal genes. While many of these interactions have been documented
previously, an integrated model for the three is still lacking. Our goal in the present study was to develop
such a model under a common set of experimental conditions.

MATERIALS AND METHODS
Media and growth conditions. Luria-Bertani liquid medium (10 g/liter tryptone, 5 g/liter yeast extract, 10
g/liter NaCl) and solid medium (15 g/liter agar) were used for routine bacterial culture and genetic
manipulation (39). Unless otherwise indicated, experiments were conducted in MOPS
(morpholinepropanesulfonic acid)-buffered glucose medium (MGC; 40 mM MOPS, 4 mM Tricine, 9.5 mM
NH4Cl, 0.276 mM K2SO4, 5 104 mM CaCl2, 0.525 mM MgCl2, and 50 mM NaCl with micronutrients, pH
7.2) using the formulation described by Neidhardt and coworkers supplemented with 20 mM glucose and
0.2% Casamino Acids as carbon sources (43). All bacterial cultures were grown at 37°C except for
strains containing plasmids pKD46, pINT-Ts, and pCP20, which were grown at 30°C. The following
antibiotics were used at the indicated concentrations: ampicillin, 100 g/ml; kanamycin, 20 g/ml; and
chloramphenicol, 20 g/ml. Salicylate, paraquat (methyl viologen), or decanoate was added to the growth
medium at 5 mM, 50 M, and 5 mM concentrations, respectively.

Strain and plasmid construction. Table 1 provides a list of all strains and plasmids used in this work.
All strains except BL21(DE3) are isogenic derivatives of the sequenced E. coli K-12 strain MG1655. The
generalized transducing phage P1vir was used in all genetic crosses according to standard methods
(57). Targeted gene deletions and subsequent marker removal were made using the bacteriophage λ
Red-recombinase method of Datsenko and Wanner (14). Site-specific integrations were made using the
Int/CRIM method of Haldimann and Wanner (18).
The soxS deletion cassette was generated using the plasmid templates pKD3 and standardized
priming sites (14). The ΔsoxS deletion cassette was generated by PCR using the primer pairs TGA ATT
AAC GAA CTG AAC ACT GAA AAG AGG CAG ATT TAT GTG TAG GCT GGA GCT GCT TCG and
AAT TAC CCG CGC GGG AGT TAA CGC GCG GGC AAT AAA ATT ACA TAT GAA TAT CCT CCT
TAG. All cassettes were transformed into MG1655 cells expressing bacteriophage λ Red-recombinase
from the pKD46 helper plasmid. Deletions were verified by PCR using primers in the antibiotic resistance
marker and sites adjacent on the host chromosome. All deletions were subsequently transduced into a
clean MG1655 or parental background prior to antibiotic cassette removal using the FLP-recombinaseexpressing pCP20 helper plasmid.
Single-copy transcriptional and translational fusions were constructed in trans using the pVenus
integration vector (53). Transcriptional fusions to the soxS, rob, and inaA promoters were made by PCR
amplifying the promoter regions of the soxS, rob, and inaA genes using primers ATA GGT ACC TTC
TCG CCA TTG GGA CGA AA and ATA GAA TTC AAG ATC CTG AAT AAT TTT CTG ATG G, ATA GGT
ACC CTG AGC TTT GCC GTT TTT AA and ATA GAA TTC AAG GTC GCG AAT AAT GCC G, and ATA
GGT ACC CAAT GCT TTT CAG CGT TAA C and ATA GAA TTC AAA TTC GTC GTA CTT TGC TG,
respectively (the underlined italic sequences represent restriction sites). Following amplification, the PCR
products were digested with KpnI and EcoRI restriction endonucleases and ligated into the
corresponding restriction sites of pVenus to produce pVenus-soxS, pVenus-rob, and pVenus-inaA. The
pVenus derivatives described above were then integrated into the phage λ attachment site in MG1655
cells expressing Int from the pINT-Ts helper plasmid. Singlecopy integrations were verified by PCR using
primers described by Haldimann and Wanner (18). The resulting single-copy fusions were transduced
back into a clean MG1655 background.
The overexpression vectors for soxS were constructed using the medium-copy, arabinose-inducible
expression vector pBAD30. The soxS-coding region was amplified by PCR using primers ATA GAA TTC
TTT ATA AGG AGG AAA AAC ATA TGT CCC ATC AGA AAA TTA TTC AG and ATA TCT AGA TTA
CAG GCG GTG GCG ATA. The resulting soxS PCR fragment was treated with EcoRI and XbaI. The
digested fragments were then ligated into the corresponding restriction sites of the pBAD30 multiplecloning site to produce pSoxS. The construct encodes a strong ribosome binding site upstream of soxS
common to pMarA and pRob to ensure high-level expression (11).
The 6 x His-Rob overexpression vector pET28a-rob was made by amplifying the rob-coding region by
PCR using primers ATA GAG CTC TTT ATA AGG AGG AAA AAC ATA TGG ATC AGG CCG GCA TTA
T and ATA GGT ACC TTA ACG ACG GAT CGG AAT CA, followed by digestion with NdeI and SacI. The
digested rob fragment was then ligated into the corresponding restriction sites of pET28a, creating an inframe 6 x His-rob-coding region and producing pET28a-rob.
Fluorescence-based promoter activity assays. Cells were grown overnight in MGC to saturation and
subcultured 1:200 in fresh medium. For experiments, 0.45 ml was dispensed to individual wells of 96well, deep, square-well microtiter plates (82006-448; VWR). Plates were sealed with Breath-Easy
membranes (Diversified Biotech) to reduce evaporation and placed on a high-speed, microplate shaker
(VWR) at 1,000 rpm and 37°C. Cultures were grown to mid-logarithmic phase (optical density [OD], 0.5)
and induced with 100 l medium containing inducer, bringing the final culture volume to 0.55 ml. Negativecontrol samples were treated with fresh medium without inducers. Growth after induction was continued
at 37°C and 1,000 rpm for 1 h prior to fluorescence and optical density measurements, unless noted
otherwise.
To measure fluorescence and optical density, 250 l of culture was transferred from the deep-well
plates to black, clear-bottomed Costar 96-well microtiter plates. Fluorescence (excitation and emission,
515 and 530 nm, respectively) and optical density (600 nm) were measured using a Tecan Safire2
microplate reader. Fluorescence measurements are reported as the relative fluorescence normalized to
the optical density of the sample to correct for variation in cell density. All experimental data presented
are the average and standard deviation of four replicate samples.

Purification of Rob. Rob purification was performed using Ni2+-affinity chromatography using an Akta
Prime fast-performance liquid chromatograph (GE Health Sciences) under native conditions. Rob was
expressed with an N-terminal 6His tag from pET28a in strain BL21(DE3). Cells were grown in 2 liters of
LB medium at 37°C and with shaking at 250 rpm to an OD of 0.7, followed by induction with 1 mM
isopropyl -D-1thiogalactopyranoside (IPTG). Cultures were grown for an additional 3 h. Cells were then
pelleted, washed once in phosphate-buffered saline (PBS; 10 mM Na2HPO4, 2 mM KH2PO4, 138 mM
NaCl, 2.7 mM KCl, pH 7.4), and repelleted. The cell pellet was then frozen at 80°C before any further
steps.
Cell pellets were thawed and resuspended in 5 ml of lysis buffer (50 mM Tris-HCl, 500 mM NaCl, 10
mM imidazole, 0.1% Triton X-100, pH 7.4) per gram of cells. Resuspended cells were then disrupted by
sonication (8 10-s pulses). Extracts were then clarified by centrifugation at 30,000 x g for 1 h, followed by
filtration through a 0.45-μm-pore-size membrane. Clarified extracts were then loaded at 1 ml/min onto a 5
ml HiTrap HP (Ni2-charged) column preequilibrated with wash buffer (50 mM Tris-HCl, 500 mM NaCl, 20
mM imidazole, pH 7.4). The column was then washed with 10 bed volumes of wash buffer, followed by
elution with wash buffer containing 150 mM imidazole. Fractions containing > 95% pure Rob (determined
by SDS-PAGE) were collected, concentrated 5 times with a 10,000-molecular-weight-cutoff concentrator
cassette (Amicon), and dialyzed against Tris-buffered saline (TBS; 50 mM Tris-HCl, 500 mM NaCl, pH
7.4). Final proteins were determined using the bicinchoninic acid assay method using bovine serum
albumin standards after trichloroacetic acid (TCA) precipitation.
ITC. All isothermal titration calorimetry (ITC) experiments were conducted using a MicroCal VP-ITC
titration calorimeter preincubated to 25°C for at least 1 h prior to the start of experiments. Rob protein
solution was brought to a final concentration of 10 M in TBS (500 mM NaCl), and the pH was measured
(typically, it was between 7.2 and 7.4) using a Perkin-Elmer pH meter. Ligand solutions were prepared
fresh in TBS, the pH of the solution was adjusted to that of the Rob solution, and the final concentration
was brought to 10 mM. The 1.4-ml sample well was loaded with a blunt-end needle attached to a 5-ml
Hamilton pipette, making sure to introduce no air bubbles into the sample cell. Likewise, the injection
syringewasfilledandexpelledwiththe10 mM ligand solution twice, prior to finally being filled and made free
of any air bubbles. The experimental parameters used with the VP-ITC system were 28 10-μl injections
at
TABLE1 Bacterial strains and plasmids used in this work
Strain or plasmid Genotype or relevant characteristicsa
Strains
MG1655
BW25141
BL21(DE3)
JW5249
JW4023
JTG1078
CR700
CR715
CR719
CR720
CR721
CR723
CR724

F- λ- ilvG rph-1
F- λ- Δ(araB-araD)567 ΔlacZ4787(::rrnB3) Δ(phoB-phoR)580 galU95
ΔuidA3::pir+ recA1 ΔendA9::FRT rph-1 Δ(rhaB-rhaD)568 hsdR514
F- ompT gal dcm lon hsdSB(rb- rm-) λ(DE3 [lacI lacUV5-T7 gene1 ind1
sam7 nin5])
F- λ- rph-1 Δ(araB-araD)567 ΔlacZ4787(::rrnB3) Δ(rhaB-rhaD)568
hsdR514 ΔmarA752::kan
F- λ- rph-1 Δ(araB-araD)567 ΔlacZ4787(::rrnB3) Δ(rhaB-rhaD)568
hsdR514 ΔsoxS756::kan
F- λ- rph-1 rfb-50 INV(rrnD-rrnE)1 rpsL179 soxR105 zjc2206::Tn10dKan
attλ::[kan marR’-yfp oriR6K]
attλ::[kan micF’-yfp oriR6K]
ΔmarRAB::FRTc
ΔsoxRS::FRT
Δrob::FRT
ΔmarRAB::FRT ΔsoxRS::FRT
ΔmarRAB::FRT Δrob::FRT

Source or
referenceb
CGSC 7740
CGSC 7635
G. W. Ordal
CGSC 11269
CGSC 10891
CGSC 7594
10
11
11
11
11
11
11

CR725
CR726
CR765
CR766
CR777
CR779
CR782
CR903
CR904
CR905
CR906
CR907
CR908
CR909
CR910
CR911
CR912
CR913
CR914
CR915
CR916
CR917
CR918
CR919
CR920
CR921
CR922
CR923
CR924
CR925
CR926
CR927
CR928
CR929
CR930
CR931
CR932
CR933
CR934
CR935
CR936
CR937

ΔsoxRS::FRT Δrob::FRT
ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT
ΔmarRAB::FRT attλ::[kan micF’-yfp oriR6K]
ΔsoxRS::FRT attλ::[kan micF’-yfp oriR6K]
Δrob::FRT attλ::[kan micF’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT attλ::[kan micF’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT attλ::[kan micF’-yfp oriR6K]
JTG1078 ΔsoxS::cat (4275086–4275406)
ΔsoxS::cat soxR105 (Kans)
ΔmarRAB::FRT ΔsoxS::cat soxR105
Δrob::FRT ΔsoxS::cat soxR105
ΔmarRAB::FRT Δrob::FRT ΔsoxS::cat soxR105
ΔmarA752::kan
ΔsoxS756::kan
ΔmarA752::FRT ΔsoxS756::FRT
ΔmarA752::FRT Δrob::FRT
ΔsoxS756::FRT Δrob::FRT
ΔmarA752::FRT ΔsoxS756::FRT Δrob::FRT
attλ::[kan soxS’-yfp oriR6K]
attλ::[kan rob’-yfp oriR6K]
attλ::[kan inaA’-yfp oriR6K]
ΔmarRAB::FRT Δrob::FRT ΔsoxS::cat ΔsoxR105 attλ::[kan marR’-yfp
oriR6K]
ΔmarRAB::FRT Δrob::FRT ΔsoxS::cat ΔsoxR105 attλ::[kan soxS’-yfp
oriR6K]
ΔmarRAB::FRT Δrob::FRT ΔsoxS::cat ΔsoxR105 attλ::[kan rob’-yfp
oriR6K]
ΔmarRAB::FRT Δrob::FRT ΔsoxS::cat ΔsoxR105 attλ::[kan inaA’-yfp
oriR6K]
ΔmarRAB::FRT attλ::[kan marR’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT attλ::[kan marR’-yfp oriR6K]
ΔmarRAB::FRT Δrob::FRT attλ::[kan marR’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT attλ::[kan marR’-yfp oriR6K]
ΔsoxS::cat ΔsoxR105 attλ::[kan soxS’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxS::cat ΔsoxR105 attλ::[kan soxS’-yfp oriR6K]
Δrob::FRT ΔsoxS::cat ΔsoxR105 attλ::[kan soxS’-yfp oriR6K]
ΔmarRAB::FRT Δrob::FRT ΔsoxS::cat ΔsoxR105 attλ::[kan soxS’-yfp
oriR6K]
Δrob::FRT attλ::[kan rob’-yfp oriR6K]
ΔmarRAB::FRT Δrob::FRT attλ::[kan rob’-yfp oriR6K]
ΔsoxRS::FRT Δrob::FRT attλ::[kan rob’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT attλ::[kan rob’-yfp oriR6K]
ΔsoxS756::FRT attλ::[kan marR’-yfp oriR6K]
Δrob::FRT attλ::[kan marR’-yfp oriR6K]
ΔsoxS756::FRT Δrob::FRT attλ::[kan marR’-yfp oriR6K]
ΔmarA752::FRT ΔsoxS756::FRT Δrob::FRT attλ::[kan marR’-yfp
oriR6K]
ΔmarA752::FRT attλ::[kan soxS’-yfp oriR6K]

11
11
11
11
11
11
11

CR938
CR939
CR940

Δrob::FRT attλ::[kan soxS’-yfp oriR6K]
ΔmarA752::FRT Δrob::FRT attλ::[kan soxS’-yfp oriR6K]
ΔmarA752::FRT ΔsoxS756::FRT Δrob::FRT attλ::[kan soxS’-yfp
oriR6K]
CR941
ΔmarA752::FRT attλ::[kan rob’-yfp oriR6K]
CR942
ΔsoxS756::FRT attλ::[kan rob’-yfp oriR6K]
(Continued on following page)
TABLE 1 (Continued)
Strain or plasmid Genotype or relevant characteristicsa
CR943
CR944
CR945
CR946
CR947
CR948
CR949
CR950
CR951
CR952

Source or
referenceb

ΔmarA752::FRT ΔsoxS756::FRT attλ::[kan rob’-yfp oriR6K]
ΔmarA752::FRT ΔsoxS756::FRT Δrob::FRT attλ::[kan rob’-yfp oriR6K]
ΔsoxRS::FRT Δrob::FRT attλ::[kan inaA’-yfp oriR6K]
ΔmarRAB::FRT Δrob::FRT attλ::[kan inaA’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT attλ::[kan inaA’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT attλ::[kan inaA’-yfp oriR6K]
ΔsoxRS::FRT Δrob::FRT attλ::[kan micF’-yfp oriR6K]
ΔmarRAB::FRT Δrob::FRT attλ::[kan micF’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT attλ::[kan micF’-yfp oriR6K]
ΔmarRAB::FRT ΔsoxRS::FRT Δrob::FRT attλ::[kan micF’-yfp oriR6K]

Plasmids
pKD46
bla PBAD gam bet exo pSC101 ori(Ts)
14
pCP20
bla cat cI857 λ PR’-flp pSC101 ori(Ts)
9
pKD3
bla rgnB FRT cat FRT oriR6K
14
pET28a
kan PT7/lacO-6 x His-MCS lacIq ColE1
Novagen
pBAD30
bla araC PBAD p15A ori
17
pMarA
pBAD30::RBS-marA
11
pRob
pBAD30::RBS-rob
11
pSoxS
pBAD30::RBS-soxS
pVenus
kan MCS yfp(venus) t0 attλ oriR6K
53
pVenus-soxS
kan MCS soxS’-yfp t0 attλ oriR6K
pVenus-rob
kan MCS rob’-yfp t0 attλ oriR6K
pVenus-inaA
kan MCS inaA’-yfp t0 attλ oriR6K
pET28a-rob
kan PT7/lacO-6 x His-rob lacIq ColE1
a Except for BL21(DE3), all strains are isogenic derivatives of E. coli K-12 strain MG1655. Numbers in
parentheses indicate deletion endpoints determined using the MG1655 genome sequence.
b All strains and plasmids are from this work unless otherwise noted. CGSC, E. coli Genetic Stock Center,
Yale University.
c FRT, FLP recombination target.
5-min intervals, a 300 rpm stirring speed, and a reference power of 1 cal/s.

RESULTS
Regulation of mar-sox-rob gene expression by ectopically expressed MarA, SoxS, and Rob. Both SoxS
and Rob are known to activate the marRAB promoter (32, 34, 40), and both MarA and SoxS are known

to repress the rob promoter (37, 38, 54). These interactions, along with other data, suggest that the marsox-rob regulon forms an integrated regulatory circuit. As a first step toward understanding this
integrated regulation, we expressed MarA, SoxS, and Rob individually from an arabinose-inducible
promoter in a marRAB soxS rob genetic background containing a constitutively active mutant of SoxR
(soxR105) (44). Note that the soxS promoter is inactive in the absence of soxR or an inducer (22, 23,
60). Use of the soxR105 allele allowed us to examine the effects of MarA, SoxS, and Rob on the soxS
promoter without needing to add an inducer for SoxR. As indirect measures of gene expression from the
marRAB, soxS, and rob promoters, single-copy transcriptional fusions to the fast-folding yellow
fluorescent protein (YFP) variant venus were employed (42). In addition, we included the downstream
inaA promoter, which is known to be activated by all three transcription factors, as a positive control in
these experiments.
As shown in Fig. 1A, MarA, SoxS, and Rob all regulate the marRAB, soxS, and rob promoters in a
sign-consistent manner, albeit with various intensities. In particular, MarA, SoxS, and Rob are all
activators of the marRAB promoter, consistent with previous studies. Likewise, MarA, SoxS, and Rob are
all repressors of the soxS and rob promoters. These results confirm the results of previous experiments,
except that it had not previously been shown that overexpressed Rob represses the rob promoter and
that overexpressed MarA and Rob repress the soxS promoter. Nonetheless, these results were
expected, as all three regulators bind the same sites by a common mechanism (24, 25, 29, 30).
Role of autoregulation on inducible expression. The preceding experiments suggest that the mar-soxrob regulon may be highly interconnected through transcriptional cross talk (Fig. 1). However, these
results were obtained from experiments where the regulators were ectopically expressed. One question,
then, is whether the same results hold when MarA, SoxS, or Rob are induced by salicylate, paraquat, or
decanoate, respectively, as opposed to being overexpressed.
MarA and SoxS are known to positively and negatively regulate their own respective expression (23,
32, 46). In addition, we found that Rob is also capable of repressing its own expression when ectopically
expressed (Fig. 1). We first tested whether these three regulators affect their own expression when
independently induced. To control for cross talk, these experiments were performed in a genetic
background where only one system was present. For example, the mar experiments were performed in a
soxS rob genetic background.

FIG1 Regulation of mar-sox-rob gene expression by MarA, SoxS, and Rob. (A) Strains contain plasmids pBAD30, pMarA,

pSoxS, and pRob and single-copy, yfp transcriptional fusions. marRAB, soxS, and rob were deleted from cells, and cells
contained a constitutively active mutant of SoxR (soxR105). Cells were grown in LB–0.2% arabinose medium for 4 h prior to
fluorescence and optical density measurements. Fluorescence values have been divided by the optical density and then
normalized to the value for the empty-plasmid (pBAD30) negative control. (B) mar-sox-rob regulatory network inferred from
the data in panel A. Darklines, interactions found to be significant under physiological conditions; graylines, interactions
found to be significant only when regulators are overexpressed. Strains used were CR917 (marRAB promoter), CR918
(soxS promoter), CR219 (rob promoter), and CR920 (inaA promoter) harboring pBAD30, pMarA, pSoxS, and pRob,
respectively.

Consistent with previous studies, marA was found to increase the activation of the marRAB promoter
in response to salicylate and soxS was found to decrease the activation of the soxS promoter in

response to paraquat (Fig. 2A and B). However, autoregulation by SoxS had only a small effect, contrary
to previous reports (46). Consistent with our overexpression experiments, rob was found to decrease the
activation of the rob promoter (Fig. 2C). The effect, however, was minor. This is consistent with a model
where Rob is regulated primarily at the posttranslational level. We also found that decanoate represses
the rob promoter and that this repression is independent of rob. Collectively, these results indicate that
autoregulation plays a significant role in inducible expression only in the case of the mar system.
Effect of inducible transcriptional cross talk on mar-sox-rob gene expression. We next investigated
cross talk and the ability of these regulators to activate each other’s expression when induced. To isolate
the affects of individual systems, the marRAB promoter experiments were performed in a marRAB
genetic background where the soxRS and/or rob operon was deleted, the soxS promoter experiments
were performed in a soxS soxR105 genetic background where the marRAB and/or rob operon was
deleted, and the rob promoter experiments were performed in a rob genetic background where the
marRAB and/or soxRS operons were deleted. Once again, we employed the soxR105 allele in these
experiments to artificially induce the soxS promoter.
In confirmation of previous reports (32), we found that paraquat activates the marRAB promoter in a
soxRS-dependent manner (Fig. 3A). Decanoate was also found to activate the marRAB promoter in a
rob-dependent manner, though weak activation was also observed in the absence of rob. Rob was also
found to increase marRAB promoter activity independently of inducer, in confirmation of previous reports
(34). These results indicate that not all Rob is in the inactive form. Likely, only a fraction aggregates
within clusters, leaving some of it in the free and active form even in the absence of its cognate inducer,
decanoate. In the case of the soxS promoter (Fig. 3B), salicylate was found to have no effect and
decanoate was found to repress it independently of rob. In the

FIG 2 Effect of autoregulation on mar-sox-rob regulon activation in the absence of genetic cross talk. Activation of the
marRAB (A), soxS (B), and rob (C) promoters during induction with 5 mM salicylate, 50 M paraquat, and 5 mM decanoate,
respectively. Strains used were CR935 and CR936 (A), CR939 and CR940 (B), and CR934 and CR935 (C). A.U.,
absorbance units.

FIG3 Effect of inducible cross talk on mar-sox-rob gene expression. (A) Activation of the marRAB promoter in response to
paraquat (PQ) and decanoate in the presence or absence of SoxS and Rob. (B) Activation of the soxS promoter in response
to salicylate and decanoate in the presence or absence of MarA and Rob. (C) Activation of the rob promoter in response to
salicylate and paraquat in the presence or absence of MarA and SoxS. Salicylate, paraquat, and decanoate were used at
concentrations of 5 mM, 50 μM, and 5 mM, respectively. Strains used were CR921 to CR924 (A), CR925 to CR928 (B), and
CR929 to CR932 (C).

FIG4 Effect of cross talk on activation of natively encoded systems observed through monitoring of the transcriptional

responses of the marRAB (A), soxS (B), and rob (C) promoters. Each system was examined in the absence of one or both
systems capable of cross regulation. Strains used were CR700 and CR933 to CR935 (A), CR914 and CR937 to CR939 (B),
and CR915 and CR941 to CR943 (C).

case of the rob promoter (Fig. 3C), we found that paraquat represses it in a soxRS-dependent manner, in
confirmation of previous reports (38). Salicylate, on the other hand, was found to activate the rob
promoter independently of the marRAB operon. This activation is enhanced in the absence of the
marRAB operon, consistent with MarA being a repressor of the rob promoter.
The results from these and the preceding experiments indicate that transcriptional cross talk is less
extensive than suggested by the overexpression experiment (Fig. 1). They also indicate that cross talk
may occur independently of MarA, SoxS, and Rob, as indicated by the repression of the soxS promoter
by decanoate and the activation of the rob promoter by salicylate. How this occurs is not known, though
in the former case, decanoate may inhibit the activity of SoxR (note that these experiments were
performed using a constitutively active variant of SoxR [soxR105]).
Effect of transcriptional cross talk on native regulation and downstream gene expression. Our
preceding results demonstrate that while cross talk is less extensive than that inferred from
overexpression experiments, it is still present nonetheless. This would suggest that cross talk may
amplify or attenuate the response of a given system to its cognate inducer. Our results also suggest that
an inducer may act through noncognate genes. For example, decanoate represses the soxS promoter
independently of Rob and salicylate activates the rob promoter independently of MarA. To determine
whether such mechanisms are present, we measured the response of the intact mar-sox-rob regulon and
downstream promoters when individual systems were selectively deleted.
In the case of salicylate and the marRAB promoter (Fig. 4A), only rob was found to have an effect.
While Rob is known to increase marRAB promoter activity in response to salicylate (34), our results
indicate that this increase is not solely due to the basal activity of Rob, as previously proposed, but is
also due to the fact that Rob is being activated by salicylate, as discussed below. We also note that
salicylate has previously been shown to activate the marRAB promoter independently of mar, sox, and
rob (12, 34, 51). In the case of paraquat and the soxS promoter (Fig. 4B), both marA and rob were found
to have little or no effect. Similarly, in the case of decanoate and the rob promoter (Fig. 4C), marA and
soxS were found to have little or no effect. In fact, our preceding results show that this repression of rob
promoter activity by decanoate is also independent of Rob itself (Fig. 3C).
We also investigated how cross talk affects the expression of downstream genes (Fig. 5). Here, we
tested the inaA and micF promoters, two known targets of MarA, SoxS, and Rob. In the case of
salicylate, activation of the inaA and micF promoters is reduced roughly 2-fold in the absence of the
soxRS and rob operons. Salicylate can also induce these two promoters through Rob independently of
MarA. While this Rob-dependent activation by salicylate is relatively minor in the case of the inaA
promoter, it yields a 2-fold increase in activity in the case of the micF promoter. In the case of paraquat,
we found that the activation of the inaA and micF promoters requires the soxRS operon and that the
degree of activation was somewhat reduced in the absence of the marRAB and rob operons, consistent
with previous observations in the case of the inaA promoter (52). Our results show that this reduction in
activity can be attributed to the loss of Rob in the case of the micF promoter; however, they do not
explain why inaA promoter activity is reduced. In the case of decanoate, we found that activation of the
inaA and micF promoters requires Rob and that the marRAB and soxRS operons have little or no effect.

Both the inaA and micF promoters are active in the absence of salicylate, paraquat, and decanoate. In
the case of the micF promoter, this basal activity can be attributed to Rob. Upon loss of Rob, this
promoter is effectively in the off state. These results suggest that Rob may play an important role in
setting the basal activity of some downstream promoters. They also demonstrate

FIG 5 Maximal activation of the downstream mar-sox-rob regulon in response to canonical inducers requires a fully intact
mar-sox-rob network. Levels of transcriptional activity of two downstream promoters, the inaA (A) and micF (B) promoters,
during exposure to the canonical mar-sox-rob inducers salicylate, paraquat, and decanoate. Strains used were CR916 and
CR945 to CR948 (A) and CR715 and CR949 to CR952 (B).

FIG 6 Rob does not directly bind salicylate. Measurements were made using a VP-ITC (MicroCal) calorimeter with purified

Rob (10 M) and 5 mM 2,2-dipyridyl (A), 5 mM salicylate (B), and 10 mM decanoate (C). Data were collected and analyzed
using the Origin-based MicroCal software suite. We also tested whether a buffer-only control with 5 mM 2,2-dipyridyl would
also yield an enthalpic change due to metal chelation. While the buffer-only control yielded an enthalpic change, it was
appreciably less than that with Rob present (data not shown).

that these regulators differentially regulate downstream promoters, consistent with the findings of
previous studies (31).
Collectively, these results (Fig. 4 and 5) suggest a further reduced model for cross talk within the marsox-rob regulon. In particular, cross talk is significant only in the case of salicylate due to its ability to
activate the mar and rob systems in parallel (Fig. 1B). Aside from cross talk, we also found that Rob sets
the basal level of expression for the micF promoter and that this basal activity can affect how strongly
this promoter is activated by paraquat through the soxRS system.
Rob responds to salicylate by an indirect mechanism. Rob alone is capable of activating the inaA and
micF promoters in response to salicylate (Fig. 5). Although several compounds such as decanoate,
dipyridyl, and deoxycholate have been observed to bind and activate Rob, salicylate is not known to bind

and activate it, to the best of our knowledge (49–51). To test for binding, we employed isothermal titration
calorimetry (ITC) using purified Rob protein titrated with a salicylate solution (Fig. 6). As controls, we also
tested whether Rob binds to 2,2-dipyridyl and decanoate. Of the three compounds tested, we observed
an appreciable enthalpic change only with 2,2-dipyridyl. No significant enthalpic changes were observed
with salicylate or decanoate, even though the latter is known to bind Rob. While the results are not
definitive, they nonetheless suggest that Rob does not directly bind salicylate and that instead salicylate
may regulate Rob at the transcriptional level.

DISCUSSION

The goal of this study was to investigate transcriptional cross talk within the mar-sox-rob regulon. While
many interactions between these systems have been identified in the past, a systematic investigation
under a common set of experimental conditions has been lacking. We found that MarA, SoxS, and Rob
all have the potential to regulate each other’s expression in a sign-consistent manner, suggesting that
the three form a fully connected network. However, this fully connected network is not realized under the
conditions tested (Fig. 1B). Only in response to salicylate did we observe any significant cross talk.
One possibility is that cross talk between the mar, sox, and rob systems becomes significant only
when two or more of these systems are activated. In particular, we do not expect SoxS, for example, to
activate the marRAB promoter when MarR is still repressing it. Similar arguments can also be extended
to the other two systems. In fact, previous studies have shown that when cells are exposed to multiple
antibiotics, the effects can be nonlinear (5, 6, 8, 61). A similar process may occur with the mar-sox-rob
regulon. We tested this hypothesis by measuring the response to different pairs of inducers (data not
shown). Our data indicate that activation of the marRAB promoter by salicylate and decanoate is simply
additive. In the case of the soxS promoter, we observed that salicylate enhances the response to
paraquat, though this effect cannot be explained by transcription cross talk between the mar and sox
systems. The two most likely work synergistically on SoxR. Otherwise, no significant interactions were
observed with two inducers. These results provide further evidence that cross talk plays only a minor role
within the mar-sox-rob regulon, aside from the interactions observed between the mar and rob systems.
This conclusion is further supported by our results where we observed limited transcriptional cross talk
when one system was constitutively active and the other two were selectively induced.
A novel finding of this study is that salicylate is capable of activating the marRAB, inaA, and micF
promoters through Rob. In the case of the marRAB promoter, Rob has previously been shown to
contribute to its activation by salicylate (34). Moreover, salicylate is known to induce the marRAB
promoter independently of mar, sox, and rob (12, 34, 51). Our contribution was to show that salicylate
activates Rob and that this activation contributes not only to the activation of the marRAB promoter by
salicylate but also to the activation of the downstream inaA and micF promoters. These results would
suggest that the marRAB operon does not form an independent regulatory system in its own right but,
rather, forms a regulatory system also involving Rob. Interestingly, this regulatory network adopts
different topologies depending on the inducer. In the case of salicylate, Rob functions in a feed-forward
loop with MarA, where it activates both the marRAB promoter and downstream ones. In response to
decanoate, however, Rob functions autonomously. Such a regulatory structure would enable decanoate
to activate a subset of the genes activated by salicylate. Consistent with this model, Warner and Levy
(58) found that cationic antimicrobial peptides activate the marRAB operon through Rob alone.
One open question is how salicylate activates Rob. The mechanism appears to be indirect, as
salicylate does not bind to Rob in vitro, as determined using isothermal calorimetry. One possibility is that
the binding of salicylate to Rob does not yield any appreciable enthalpic change. Rather, binding could
yield an entropic change, possibly by disordering the protein (7, 59). Such a binding mechanism would
not be detected using isothermal calorimetry. In fact, we were unable to detect the binding of decanoate
to Rob using this method. An alternate possibility is that salicylate increases the expression of rob. Our
data (Fig. 3C) show that salicylate activates the rob promoter independently of the marRAB operon. If
anything, marA seems to attenuate this response. Whether this increase in promoter activity is sufficient
to activate Rob is unknown. What is clear is that not all Rob is in the inactive form (Fig. 3A). This would
imply that Rob can also be controlled at the transcriptional level, as increased expression of rob would
also increase the concentration of Rob in the free and active form.

We also do not know how salicylate is able to activate the rob promoter. What is known is that
salicylate also activates the marRAB promoter independently of MarR, MarA, SoxS, and Rob (32, 34).
EmrR, a transcription factor also responsive to salicylate, is also known not to be involved (34). In
addition, we found that decanoate represses the soxS and rob promoters and induces the marRAB
promoter independently of Rob. Again, the mechanisms are unknown.
One limitation of our experimental analysis is that we did not control for the action of downstream
genes. In particular, the mar-sox-rob regulon includes a number of genes that encode efflux transporters
and other detoxifying systems (3, 4, 35, 48). In our experiments, where we selectively deleted different
systems, it is possible that we were affecting the ability of the cells to adapt to these chemical stresses. If
such a process were occurring, the various mutants used in this study would become hypersensitive to
the compounds tested. However, we did not observe such an effect.
In conclusion, we have systematically mapped the interactions between the marRAB, soxRS, and rob
operons under a common set of experimental conditions. The main contribution of this work was to show
that transcriptional cross talk is limited under physiological conditions, even though multiple studies have
previously suggested otherwise. Only the marRAB operon was found to be subject to appreciable cross
talk through its interactions with Rob. Moreover, our results suggest that the marRAB and rob operons
function together in a conditional manner and that the two systems should not be viewed as autonomous
systems but rather as an integrated network in their own right.
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